The rapid increase in both the lifespan and proportion of older adults is accompanied by the
unprecedented rise in age-associated chronic diseases, including sarcopenia and obesity …

Mesenchymal stem cell (MSC) therapy is an emerging treatment strategy to counteract
metabolic syndromes, including obesity and its comorbid disorders. However, its …

Obesity is a critical risk factor for the development of metabolic diseases, and its prevalence
is increasing worldwide. Stem cell‐based therapies have become a promising tool for …

Mesenchymal stromal cell (MSC) therapy has seen increased attention as a possible option
to treat a number of inflammatory conditions including COVID-19 acute respiratory distress …

Common characteristics of aging include reduced somatic stem cell number, susceptibility to
cardiac injuries, metabolic imbalances and increased risk for oncogenesis. In this study …

In numerous body locations, muscle and adipose tissue are in close contact. Both tissues
are endocrine organs that release cytokines, playing a crutial role in the control of tissue …

Obesity is a complex worldwide disease, characterized by an abnormal or excessive fat
accumulation. The onset of this pathology is generally linked to a complex network of …

Abstract Type 2 diabetes (T2D), associated with obesity, represents a state of metabolic
inflammation and oxidative stress leading to insulin resistance and progressive insulin …

Obesity is a highly prevalent condition often associated with dysfunctional adipose tissue.
Stem cell-based therapies have become a promising tool for therapeutic intervention in the …

Diabetes mellitus is a highly prevalent disease characterized by hyperglycaemia that
damages the vascular system, leading to micro‐(retinopathy, neuropathy, nephropathy) and …